Emergent Biosolutions ( (EBS) ) has shared an announcement. On October 29, 2025, Emergent BioSolutions reported its financial results for the third quarter of 2025, with total revenues of $231.1 ...

Q3 2025 Earnings Call Transcript October 29, 2025 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is ...

Dental products company Envista Holdings (NYSE:NVST) reported Q3 CY2025 results topping the market’s revenue expectations, ...

Sprouts Farmers Market Inc (NASDAQ:SFM) stock is down 25.7% to trade at $77.71 and trading at 52-week lows, after sales growth missed Wall Street's expectations. No fewer than eight analysts slashed ...

Envista Holdings Corporation ( NVST) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT ...

Discover Q3 2025 highlights for Emergent BioSolutions: raised revenue guidance, strong naloxone sales, and margin growth.

Traditionally, the term “ braindump ” referred to someone taking an exam, memorizing the questions, and sharing them online for others to use. That practice is unethical and violates certification ...

Envista Logo (PRNewsfoto/Envista Holdings Corporation) "This was another strong quarter for Envista, with core growth, adjusted EBITDA, and adjusted EPS all ahead of expectations, ...

Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the third quarter ended September 30, 2025.